Skip to content

Providing next-generation regenerative medicine

Addressing the biggest global unmet clinical needs in tissue regeneration

Renovos offers a step change in tissue repair approaches with an exciting new biomaterial platform.

rotating spine showing precise injection

Renovos offers a step change in tissue repair approaches with an exciting new biomaterial platform.

rotating spine showing precise injection
trab bones

The Need for New Approaches

Welcome increase in life expectancy has led to a rise in age-related diseases and healthcare costs. In addition to the ageing world population, increasingly active younger demographics are also prone to trauma, injury or disease. All these result in tissue deterioration for which new regenerative approaches are desperately needed.

vials in lab

Our Mission

We are pioneering a nanoclay gel technology platform, RENOVITE®, for medical applications to address the unmet need for effective long term tissue regeneration, offering safer, more economic clinical solutions for health systems, and better outcomes for patients, to help them remain active for longer.

nanoclay injectable gel

The Science

Our proprietary platform technology, RENOVITE®, acts as injectable scaffold which attracts regenerative cells and templates new tissue formation. It localises and retains delivered biologics, allowing their use at ultra-low effective doses for safer and more efficient applications in tissue regeneration.

RENOVITE®

synthetic nanoclay therapeutic delivery platform

Revolutionary platform technology, RENOVITE®, uses synthetic nanoclay gels to safely and precisely deliver therapeutic agents for regenerative medicine.
Richard Oreffo of Renovos in the laboratory

Transforming Patient Lives

Regenerative medicine – the use of new stem cell and material technologies – holds the promise of improving the healing process and therefore relieve pain and return patients to normal life sooner. Renovos aims to help develop and augment treatment plans to repair and replace diseased or damaged tissues to transform lives, for both active living and healthy ageing. We offer a proprietary regenerative medicine technology, RENOVITE®, based on nanoclays.
trab bones

The Need for New Approaches

Welcome increase in life expectancy has led to a rise in age-related diseases and healthcare costs. In addition to the ageing world population, increasingly active younger demographics are also prone to trauma, injury or disease. All these result in tissue deterioration for which new regenerative approaches are desperately needed.

vials in lab

Our Mission

We are pioneering a nanoclay gel technology platform, RENOVITE®, for medical applications to address the unmet need for effective long term tissue regeneration, offering safer, more economic clinical solutions for health systems, and better outcomes for patients, to help them remain active for longer.

nanoclay injectable gel

The Science

Our proprietary platform technology, RENOVITE®, acts as injectable scaffold which attracts regenerative cells and templates new tissue formation. It localises and retains delivered biologics, allowing their use at ultra-low effective doses for safer and more efficient applications in tissue regeneration.

RENOVITE®

synthetic nanoclay therapeutic delivery platform

Revolutionary platform technology, RENOVITE®, uses synthetic nanoclay gels to safely and precisely deliver therapeutic agents for regenerative medicine.
Richard Oreffo of Renovos in the laboratory

Transforming Patient Lives

Regenerative medicine – the use of new stem cell and material technologies – holds the promise of improving the healing process and therefore relieve pain and return patients to normal life sooner. Renovos aims to help develop and augment treatment plans to repair and replace diseased or damaged tissues to transform lives, for both active living and healthy ageing. We offer a proprietary regenerative medicine technology, RENOVITE®, based on nanoclays.

Partnering Opportunities

Our RENOVITE® nanoclay technology has been refined and developed over years of academic research, innovation, rigorous testing and validation. Renovos welcomes enquiries from potential partners that might wish to utilise our RENOVITE® nanoclay in their own biologics or device development programmes or with an interest in partnering in one of Renovos’ in-house developments.
Innovate UK logo
orthopaedic research uk logo
Royal Society of Chemistry Enterprise logo
University of Southampton logo
Solent LEP logo